We scan new podcasts and send you the top 5 insights daily.
Unlike venture capital, private equity investment theses should not depend on building a new product for a new market. Entering a deal with this requirement is a significant red flag, as PE focuses on optimizing existing, proven models, not high-risk, venture-style exploration.
Prelude Growth Partners' framework avoids investments with product, category, or brand risk. Instead, they focus on opportunities where the primary uncertainty is execution, as they believe they can actively help mitigate that risk post-investment. This clarifies the type of risk growth capital should take on.
Rather than competing in crowded auctions, elite private equity firms pursue a differentiated "executive new build" strategy. They partner with proven operators to build new companies from scratch to address a market need, creating proprietary deals that other firms cannot access.
A common mistake in venture capital is investing too early based on founder pedigree or gut feel, which is akin to 'shooting in the dark'. A more disciplined private equity approach waits for companies to establish repeatable, business-driven key performance metrics before committing capital, reducing portfolio variance.
The typical 5-year (60-month) investment horizon for private equity firms is too short to accommodate the uncertainty required for a successful 'diversification' strategy (new product, new market). This constraint forces PE-backed firms to focus on less speculative growth quadrants.
Unlike venture-backed startups that chase lightning in a bottle (often ending in zero), private equity offers a different path. Operators can buy established, cash-flowing businesses and apply their growth skills in a less risky environment with shorter time horizons and a higher probability of a positive financial outcome.
Private equity firms often create overly specific M&A plans, seeking perfect-fit companies. This approach fails because the market rarely offers these 'unicorns.' Success requires planning for ambiguity and acquiring good-but-imperfect businesses, as you can only buy what's for sale.
Unlike venture capital, which invests in founders to create new products, private equity acquires existing companies to extract value through financial tactics. The goal is making money from money, not necessarily improving the core business.
When fundraising, pitch the creation of a new market category, not just a better product. Investors view incremental improvements as capped opportunities fighting for existing market share. They disproportionately fund 'different' companies that can create, own, and dominate an entirely new market space.
PE deals, especially without a large fund, cannot tolerate zeros. This necessitates a rigorous focus on risk reduction and what could go wrong. This is the opposite of angel investing, where the strategy is to accept many failures in a portfolio to capture the massive upside of the 1-in-10 winner.
Product management in a Private Equity (PE) firm differs fundamentally from a Venture Capital (VC) context. PE firms demand a delivery-focused approach to meet 3-5 year exit timelines, de-prioritizing open-ended discovery. Product leaders must adopt this commercial mindset to succeed, as they are ultimately working for a financial institution, not a founder.